Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges

SIMPLE SUMMARY: Human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (mBC) represents a subgroup of breast cancer characterized by an aggressive behaviour and a particular sensitiveness to HER2-targeted agents. Because of the frequent occurrence of acquired resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guidi, Lorenzo, Pellizzari, Gloria, Tarantino, Paolo, Valenza, Carmine, Curigliano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954056/
https://www.ncbi.nlm.nih.gov/pubmed/36831473
http://dx.doi.org/10.3390/cancers15041130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954056/
https://www.ncbi.nlm.nih.gov/pubmed/36831473
http://dx.doi.org/10.3390/cancers15041130

Ejemplares similares